Menu

Category: Providers

Providers Try a Range of Responses to Manufacturer 340B Contract Pharmacy Restrictions

Rich Daly, Editor in Chief Views
Colleen Meiman
Community health centers are attempting to mitigate the adverse financial effects of manufacturer 340B contract pharmacy restrictions on their organizations, said Colleen Meiman, national policy advisor for State & Regional Associations of Community Health Centers.
Amid an increasing number of drugmaker restrictions and requirements on the use of contract pharmacies, 340B providers are trying a [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
…
Read More »

Expanding 340B Eligibility Could Double Program Size, Says Report

William Newton, Associate Editor/Senior Writer Views
IQVIA headquarters
An IQVIA analysis looked at the 340B program’s growth under the Affordable Care Act.
The 340B program could more than double in size if the 340B patient definition expands, according to a recent report [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
…
Read More »

Senate Committee Rejects 340B Amendment to Bipartisan Health Bill

William Newton, Associate Editor/Senior Writer Views
Bernie Sanders
Sen. Bernie Sanders, chair of the Senate HELP committee, opposed an amendment that would implement 340B hospital verification requirements.
A Senate committee rejected an effort to add new 340B hospital verification requirements as part of a sweeping healthcare funding [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
…
Read More »

Federal Appeals Court Judges Press Both Sides in Key Hearing on Arkansas 340B Contract Pharmacy Law

William Newton, Associate Editor/Senior Writer Views
Chief Judge Lavenski Smith of the 8th Circuit Court of Appeals and two other federal judges heard highly anticipated oral arguments for PhRMA v. McClain in a case that challenges Arkansas' 340B contract pharmacy law.
Attorneys representing Arkansas and 340B providers sparred with a drug industry lawyer over the constitutionality of Arkansas’ first-in-the-nation 340B contract [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
…
Read More »

Incyte Becomes 26th Drugmaker to Place Contract Pharmacy Restrictions

Rich Daly, Editor in Chief Views
Incyte will no longer allow 340B hospitals to have direct delivery of Opzelura products purchased at the 340B discount price to contract pharmacies.
Drug manufacturer Incyte Corp. this week announced it will become the 26th drug manufacturer to restrict access to 340B pricing when [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
…
Read More »

One Quarter of HRSA Provider Audits Closed with No Adverse Findings

Rich Daly, Editor in Chief Views
Dept. of Health and Human Services sign and building
There were no adverse findings in nearly one quarter of provider audits conducted by HRSA, an agency within HHS.
Nearly one-quarter of the 200 provider audits planned for this year were closed by regulators with no adverse findings, they [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
…
Read More »

Providers Split on 340B Medicaid Provisions in Major House Healthcare Package

William Newton, Associate Editor/Senior Writer Views
Joe Dunn, senior vice president of public policy and research at NACHC, said his organization supported the Lower Costs, More Transparency Act.
Provider groups diverged over 340B Medicaid managed care provisions in a sweeping healthcare package on which the House of Representatives [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
…
Read More »

AHF Files Appeal Over Its Claim That Apexus Did Not Obtain Sub-Ceiling Discounts

Rich Daly, Editor in Chief Views
Judge Percy Anderson
AHF appealed a ruling to dismiss by U.S. District Judge Percy Anderson over AHF's claim that Apexus did not obtain sub-ceiling discounts..
The AIDS Healthcare Foundation (AHF) recently filed an appeal to an April district court dismissal of its case against Apexus, [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
…
Read More »

Health Center Challenging 340B Patient Definition Responds to HRSA’s and Drug Companies’ Court Arguments

Tom Mirga, Editor at Large Views
Genesis
Genesis Health Care successfully challenged HRSA's 340B patient definition in the U.S. District Court for the District of South Carolina.
There is no evidence to support federal allegations that a South Carolina community health center illegally diverts 340B-purchased drugs to [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
…
Read More »

Novo Nordisk Providing 340B Refunds on Blockbuster Drug Ozempic

Tom Mirga, Editor at Large Views
Ozempic package
Drugmaker Novo Nordisk is issuing 340B refunds for certain purchases of its blockbuster diabetes medication Ozempic.
Novo Nordisk will issue refunds to 340B covered entities for some purchases this year of its blockbuster injectable diabetes medication [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
…
Read More »
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
×

*Sign up for news summaries and alerts from 340B Report

Site Footer Live